Communities Fighting COVID-19!
Communities Fighting COVID!
2 other identifiers
interventional
32,750
1 country
1
Brief Summary
To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Oct 2020
Longer than P75 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2020
CompletedFirst Submitted
Initial submission to the registry
March 31, 2021
CompletedFirst Posted
Study publicly available on registry
December 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 25, 2023
CompletedJune 14, 2024
June 1, 2024
2.8 years
March 31, 2021
June 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Test uptake
Testing volume by study arm as cumulative count per hours testing site operated
Through study completion, expected to be 20 months
Secondary Outcomes (3)
Test access
Through study completion, expected to be 20 months
Test Impact (COVID-19 diagnoses)
Through study completion, expected to be 20 months
Test Impact (number needed to screen)
Through study completion, expected to be 20 months
Study Arms (4)
At home testing (Aim 1)
EXPERIMENTALHigh-risk friends and family of contacts exposed to COVID-19 will be provided with COVID-19 testing provided at home by a healthcare worker.
Mobile testing (Aim 1)
ACTIVE COMPARATORHigh-risk friends and family of contacts exposed to COVID-19 will be referred to study operated mobile testing sites in the community for COVID-19 testing.
Mobile testing approach 1 (Aim 2)
OTHERMobile testing utilizing active outreach
Mobile testing approach 2 (Aim 2)
OTHERMobile testing utilizing baseline outreach approaches
Interventions
Implementation of Antigen and PCR testing at participant homes
Implementation of Antigen and PCR testing at mobile test sites
Implementation of Antigen and PCR testing at mobile test sites - active outreach
Implementation of Antigen and PCR testing at mobile test sites - baseline outreach
Eligibility Criteria
You may qualify if:
- African American, Arabic speaking, Filipino, and Latino/a populations
You may not qualify if:
- Younger than 6, not in focus populations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- San Diego State Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Contact Households
San Diego, California, 92182, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan M Kiene, PhD
San Diego State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 31, 2021
First Posted
December 8, 2021
Study Start
October 25, 2020
Primary Completion
August 25, 2023
Study Completion
August 25, 2023
Last Updated
June 14, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Shared on a periodic basis. RPPR shared with NIH on a 6-month basis
- Access Criteria
- Anonymized data access
Plan to share with Rad-X UP Coordinating Center